Frédérique Bard

5.3k total citations
25 papers, 1.6k citations indexed

About

Frédérique Bard is a scholar working on Physiology, Computational Theory and Mathematics and Neurology. According to data from OpenAlex, Frédérique Bard has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 7 papers in Computational Theory and Mathematics and 7 papers in Neurology. Recurrent topics in Frédérique Bard's work include Alzheimer's disease research and treatments (14 papers), Computational Drug Discovery Methods (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Frédérique Bard is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), Computational Drug Discovery Methods (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Frédérique Bard collaborates with scholars based in United States, Netherlands and Germany. Frédérique Bard's co-authors include Peter Seubert, Dale Schenk, Dora Games, Leslie Crews, Eliezer Masliah, Paul D. Wes, Li Gan, Faten A. Sayed, Laura Hansen and Anthony Adame and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Neuroscience.

In The Last Decade

Frédérique Bard

25 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédérique Bard United States 16 1.0k 652 450 281 225 25 1.6k
Luca Bondolfi Switzerland 10 1.3k 1.3× 534 0.8× 594 1.3× 352 1.3× 252 1.1× 10 1.7k
Allal Boutajangout United States 18 1.2k 1.2× 579 0.9× 499 1.1× 378 1.3× 344 1.5× 32 1.6k
Paige E. Cramer United States 7 1.2k 1.1× 490 0.8× 785 1.7× 379 1.3× 262 1.2× 7 2.0k
Jessica Koenigsknecht-Talboo United States 9 1.4k 1.4× 1.1k 1.7× 633 1.4× 354 1.3× 222 1.0× 9 2.3k
Qingli Xiao United States 18 1.2k 1.2× 634 1.0× 638 1.4× 382 1.4× 170 0.8× 25 2.0k
Mary Lou Previti United States 18 930 0.9× 591 0.9× 409 0.9× 236 0.8× 118 0.5× 27 1.5k
Janaky Coomaraswamy Germany 15 1.6k 1.6× 806 1.2× 1.1k 2.5× 376 1.3× 232 1.0× 18 2.3k
Sakura Minami United States 17 850 0.8× 419 0.6× 472 1.0× 322 1.1× 226 1.0× 37 1.5k
Ilie‐Cosmin Stancu Belgium 14 992 1.0× 511 0.8× 696 1.5× 293 1.0× 144 0.6× 17 1.5k
Suizhen Lin United States 16 943 0.9× 833 1.3× 738 1.6× 629 2.2× 171 0.8× 24 2.2k

Countries citing papers authored by Frédérique Bard

Since Specialization
Citations

This map shows the geographic impact of Frédérique Bard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédérique Bard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédérique Bard more than expected).

Fields of papers citing papers by Frédérique Bard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédérique Bard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédérique Bard. The network helps show where Frédérique Bard may publish in the future.

Co-authorship network of co-authors of Frédérique Bard

This figure shows the co-authorship network connecting the top 25 collaborators of Frédérique Bard. A scholar is included among the top collaborators of Frédérique Bard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédérique Bard. Frédérique Bard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barbour, Robin, et al.. (2021). Development of a dual Aβ‐tau vaccine for the prevention of Alzheimer’s disease. Alzheimer s & Dementia. 17(S9). 1 indexed citations
2.
Li, Xinyi, Wouter Koudstaal, Lauren Fletcher, et al.. (2019). Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology. Acta Neuropathologica. 137(5). 825–836. 44 indexed citations
3.
Tulloch, Jane, Stéphanie Daumas, Linda Ferrington, et al.. (2016). Early detection of cryptic memory and glucose uptake deficits in pre-pathological APP mice. Nature Communications. 7(1). 11761–11761. 14 indexed citations
4.
Shah, Disha, Jelle Praet, Corinna Höfling, et al.. (2016). Early pathologic amyloid induces hypersynchrony of BOLD resting‐state networks in transgenic mice and provides an early therapeutic window before amyloid plaque deposition. Alzheimer s & Dementia. 12(9). 964–976. 66 indexed citations
5.
Blockx, Ines, Pieter‐Jan Guns, Johan Van Audekerke, et al.. (2016). Monitoring Blood-Brain Barrier Integrity Following Amyloid-β Immunotherapy Using Gadolinium-Enhanced MRI in a PDAPP Mouse Model. Journal of Alzheimer s Disease. 54(2). 723–735. 17 indexed citations
6.
Mably, Alexandra J., Wen Liu, Jessica M. Mc Donald, et al.. (2015). Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice. Neurobiology of Disease. 82. 372–384. 35 indexed citations
7.
Gardai, Shyra J., Birgitt Schüle, M. A. Babcock, et al.. (2013). Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease. PLoS ONE. 8(8). e71634–e71634. 83 indexed citations
8.
Bradshaw, J. Michael, Lan K. Nguyen, William H. Wallace, et al.. (2012). Monitoring Signaling by the p75 NTR Receptor Utilizing a Caspase-3 Activation Assay Amenable to Small-Molecule Screening. Assay and Drug Development Technologies. 10(4). 353–364. 3 indexed citations
9.
Bard, Frédérique, Michael Fox, Stuart Friedrich, et al.. (2012). Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice. Experimental Neurology. 238(1). 38–43. 40 indexed citations
10.
Zago, Wagner, Manuel Buttini, Thomas A. Comery, et al.. (2012). Neutralization of Soluble, Synaptotoxic Amyloid β Species by Antibodies Is Epitope Specific. Journal of Neuroscience. 32(8). 2696–2702. 53 indexed citations
11.
Neitz, R. Jeffrey, Andrei W. Konradi, Hing L. Sham, et al.. (2011). Highly selective c-Jun N-terminal kinase (JNK) 3 inhibitors with in vitro CNS-like pharmacokinetic properties II. Central core replacement. Bioorganic & Medicinal Chemistry Letters. 21(12). 3726–3729. 14 indexed citations
12.
Shapiro, Reneé, Tatiana Plavina, Brian Schlain, et al.. (2011). Development and validation of immunoassays to quantify the half-antibody exchange of an IgG4 antibody, natalizumab (Tysabri®) with endogenous IgG4. Journal of Pharmaceutical and Biomedical Analysis. 55(1). 168–175. 28 indexed citations
13.
Bova, Michael P., et al.. (2011). A Label-Free Approach to Identify Inhibitors of α4β7-Mediated Cell Adhesion to MadCAM. SLAS DISCOVERY. 16(5). 536–544. 2 indexed citations
14.
Tesseur, Ina, Kun Zou, Luke Esposito, et al.. (2006). Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathology. Journal of Clinical Investigation. 116(11). 3060–3069. 287 indexed citations
15.
Lee, Michael, Frédérique Bard, Kelly Johnson‐Wood, et al.. (2005). Aβ42 immunization in Alzheimer's disease generates Aβ N-terminal antibodies. Annals of Neurology. 58(3). 430–435. 107 indexed citations
16.
Masliah, Eliezer, Laura Hansen, Anthony Adame, et al.. (2005). Aβ vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology. 64(1). 129–131. 281 indexed citations
17.
Bussière, Thierry, Frédérique Bard, Robin Barbour, et al.. (2004). Morphological Characterization of Thioflavin-S-Positive Amyloid Plaques in Transgenic Alzheimer Mice and Effect of Passive Aβ Immunotherapy on Their Clearance. American Journal Of Pathology. 165(3). 987–995. 130 indexed citations
18.
Seubert, Peter, Michael H. Lee, Frédérique Bard, et al.. (2004). P4-401 Characterization of the humoral response to AN1792 immunization in AD patients. Neurobiology of Aging. 25. S588–S588. 1 indexed citations
19.
Games, Dora, Frédérique Bard, Terry Guido, et al.. (2000). Prevention and Reduction of AD‐type Pathology in PDAPP Mice Immunized with Aβ1–42. Annals of the New York Academy of Sciences. 920(1). 274–284. 36 indexed citations
20.
Horner, Heidi C., Frédérique Bard, Damien Hall, et al.. (1992). Permeation of the Blood-Brain Barrier for Drug Delivery to the Brain. PsycEXTRA Dataset. 120. 218–29. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luca Bondolfi Breakdown of academic impact, for papers by Allal Boutajangout Breakdown of academic impact, for papers by Paige E. Cramer Breakdown of academic impact, for papers by Jessica Koenigsknecht-Talboo Breakdown of academic impact, for papers by Qingli Xiao Breakdown of academic impact, for papers by Mary Lou Previti Breakdown of academic impact, for papers by Janaky Coomaraswamy Breakdown of academic impact, for papers by Sakura Minami Breakdown of academic impact, for papers by Ilie‐Cosmin Stancu Breakdown of academic impact, for papers by Suizhen Lin
Rankless by CCL
2026